Abstract 1932: Mutations in ATRX increase genetic instability and sensitivity to PARP inhibitors in paediatric glioblastoma cells
Janat Fazal-Salom(Institute of Cancer Research), Chris Jones(North Carolina State University), Helen N. Pemberton(Institute of Cancer Research), Alan Mackay(Institute of Cancer Research), Diana Carvalho(Institute of Cancer Research), Stephen J. Pettitt(Gene Therapy Laboratory), Christopher J. Lord(Institute of Cancer Research), Lynn Bjerke(Institute of Cancer Research), Maria Vinci(Cancer Research UK)
Cited by 2
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k